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Conclusion: Prevalence of cardiac involvement was 44%. Only
5% symptomatic. Mean CD4 lower in patients with cardiac disor-
der than those without. Lower CD4 count significantly associated
with pericardial effusion. 45% of the patients were receiving
ART and 55% were not. Noninvasive investigations like echocar-
diography helps in early diagnosis of asymptomatic cardiac dis-
orders. Cardiac disorders in HIV infected patients and only small
percentage of the patients with cardiac disorders are symptom-
atic.
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Background: Achieving adequate hemostasis in blind pacemaker
pocket is difficult. Pacemaker site hematoma with its attendant
complications is a frequent occurrence (17-25%) after permanent
pacemaker Implantation(PPI) especially in patients of ischemic
and valvular heart disease on anticoagulation and antiplatelet
therapy.
Methods: 84 patients requiring PPI were included in present study.
61 (72%) Patients were male, 23 (27%) patients were females. Clin-
ical presentation was syncope in 35 (41%) patients, complete heart
block in 46 (54%), Symptomatic sinus & Junctional Bradycardia in
10 cases (5%). 27 (32%) patients had coronary artery disease and
were on dual antiplatelets therapy with Ecosprin and Clopidogrel
/Prasugrel. Two ( 2.4%) patients of rheumatic heart diseasewere on
Acitrom. 89% patient received single chamber and 11% patient
received dual chamber pacemakers. Permanent Pacemaker was
implanted in routine manner in right infraclavicular fossa. As a
part of protocol MINI VAC closed wound suction drainage system
was placed into pacemaker pocket through separate dependent
portion of pacemaker site. Injection Targocid , Piptazwere used for
two days in therapeutic dosage as per hospital protocol. Patients
were discharged after 48 hours after removal of vacuum suction
drainage system and wound dressing. Patients were followed for
period of three months on regular basis.
Results: There was no incidence of pacemaker site hematoma,
local pain or tenderness, infection during hospital stay in all 84
patients. Neither these end points were observed during follow
period of three months.
Conclusion: Permanent pacemaker hematoma can be avoided
with routine use of vacuum suction drainage system placement
during permanent pacemaker implantation. There is no risk of
pacemaker pocket infection requiring repeated hospital admis-
sions and risk of explantation.
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Background: Radiofrequency ablation (RFA) for VT is an estab-
lished therapy in patients with ICD to reduce the number of
shocks. As many of our patients could not afford ICD, we offered
RFA as a primary therapy to these patients. We present our
experience of RF VT ablation in Indian population.
Methods: Patients who underwent RFA for VT ablation in our
centre from January 2008 toMay 2013 formed the study group.
Patients were categorized as Group I (with ICD) and Group II
(without ICD). Time-to-event analysis was performed. The pri-
mary end-points studied were VT recurrence and all-cause
mortality.
Results: Of 48 patients who underwent procedure,17 were in
Group I and 31 in Group II.
Median time-interval between ICD implantation and RFA in
Group I was 3yrs (Range: 1-12years). One hundred thirty nine
morphologically distinct ventricular tachycardias were induced in
the lab with an average of 2.6 VTs per patient. Hemodynamically
unstable or nonsustained VTs were 55% and hemodynamically
stable and sustained were 45%. Freedom from recurrence of VT
was observed in 77%with complete procedural success and 53% of
patients with partial success or procedure failure (p ¼ 0.22). The
freedom from recurrent VTs was 45% (N¼9) in Group I and 86%
(N¼3) in Group II (p¼0.0034) (Fig.1). Two patients had procedure
failure. All cause mortality was 4% (N¼2). There were no
arrhythmic deaths.
Conclusion: VT ablation is a safe procedure and can be considered
as a primary therapy in patients who cannot afford an ICD. In
patients with ICD, early preventive VT ablation at the time of ICD
implantation may be better than later curative therapy for
recurrent shocks.
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Background: There is no data on indications, clinical character-
istics of patients and type of cardiac implantable electrical devices
(CIED), including pacemakers, intracardiac defibrillators (ICD) and
cardiac resynchronization therapy (CRT) in India.
Aim: The CIED survey was conducted to document the type of
devices used, indications and capture demographic characteris-
tics, clinical status and co-morbidities of patients undergoing
these implants in India.
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